Translational Development Acquisition (NASDAQ:TDACU) Trading 3.3% Higher – Still a Buy?

Shares of Translational Development Acquisition Corp. (NASDAQ:TDACU) traded up 3.3% on Friday . The company traded as high as $10.90 and last traded at $10.81. 2,600 shares changed hands during mid-day trading, a decline of 85% from the average session volume of 17,917 shares. The stock had previously closed at $10.46.

Translational Development Acquisition Stock Up 3.3%

The stock has a 50 day moving average of $10.60 and a two-hundred day moving average of $10.50.

Translational Development Acquisition Company Profile

Translational Development Acquisition Corp. is a blank check acquisition company incorporated in Delaware. The company was formed to effect a merger, stock purchase, asset acquisition, stock exchange, reorganization or similar business combination with one or more businesses, though it has not yet identified a target for its initial transaction.

In early 2021, the company completed its initial public offering and listed its units on the Nasdaq under the ticker TDACU. Each unit comprises one Class A ordinary share and one-third of a warrant to purchase additional Class A shares, with its securities also trading separately as shares and warrants.

Following its IPO, the net proceeds from the offering are held in a trust account until the closing of an initial business combination.